MBD
Latest round
- Series C
Last raised
- Aug 2025
Total raised
- $31M
Investors
- 19
About MBD
Based in Suwon-si, South Korea, and founded in 2015, MBD is a biotechnology company that uses 3D cell culture platform technology to develop drug efficacy and toxicity for anti-cancer drugs. In 2018, MBD developed a treatment platform for liver cancer patients in Singapore. In 2019, MBD's products such as ASFA Spotter and ASFA Scanner were approved by the FDA. The company's team of researchers and engineers have developed 3D cell cultivation platform for cell biology research and drug screening such as Cellvitro, ASFA Spotter, and ASFA Scanner. MBD uses 3D cell culture technology to extract cancer cell samples to develop anti-cancer treatments. The company plans to develop different types of medical devices for detecting ovarian cancer and breast cancer. The company has collaborated with research institutes to begin clinical trials for European patients.
Who invested in MBD
19 investors across 3 rounds
See all investors in MBD
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MBD
Who invested in MBD?
MBD has 19 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MBD raised?
MBD has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did MBD last raise money?
MBD's most recent round on record is a Series C, in Aug 2025.
What does MBD do?
Based in Suwon-si, South Korea, and founded in 2015, MBD is a biotechnology company that uses 3D cell culture platform technology to develop drug efficacy and toxicity for anti-cancer drugs.
Where is MBD headquartered?
MBD is headquartered in Suwon, South Korea.
Which VCs invest in companies like MBD?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MBD's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like MBD? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.